Advanced wireless technologies and novel approaches to DM therapeutics that once were unimaginable continue to refine diabetes management.
Image ©Sergey Nivens/Shutterstock.com
Interesting Endo: AFib, Bone Health, and Obesity
At-a-Glance: Studies you may find of interest look at AFib in T1DM, new fracture risk data, obesity outcomes, and more.
Lifestyle Intervention Reduces Need for Diabetes Medications
In a new study, an intensive lifestyle intervention did not markedly decrease A1c but had significant impact on need for medication.
The Artificial Sweetener Paradox: Weight Gain and Metabolic Dysfunction?
A new meta-analysis finds that routine intake of artificial sweeteners is linked to the opposite of the intended effect.
Diabetes Care: How to Close the Gap Between Where We Are and Where We Could Be
Here: 3 strategies that can help fuel the patient's drive to change.
Telemedicine in Type 2 Diabetes Care: Two Stories of Success
A successful lifestyle intervention for advanced diabetes and improved access to diabetic eye care for rural patients showcase telemedicine at its best.
Endocrinology News Quiz: Obesity and Osteoporosis
Are you up-to-date on new studies about bisphosphonates, body-fat measurement, prebiotics, and insulin dosing? Find out with our quiz.
Interesting T2D: Gaming, Drinking, and Diabetes Outcomes
Slide Show: Highlights of new research on online diabetes games, benefits of alcohol, and predictors of T2DM remission.
Diabetes Self-Management: Nurse-Led Approach
Patients were randomized to standard care, nurse-led education intervention, or nurse-led education plus acceptance therapy.
Renal Effects: SGLT2 Inhibitors in Type 2 Diabetes
A meta-analysis compared the renal side effects of SGLT2 inhibitors in patients with type 2 diabetes.
CV Events: Safety of Insulin
A study compared mortality and major adverse cardiovascular events in patients with type 2 diabetes prescribed metformin or insulin.
Can Liraglutide Delay Diabetes Onset?
Researchers compared time to onset of diabetes in a group of patients with obesity and pre-diabetes treated with liraglutide or placebo.
By clicking Accept, you agree to become a member of the UBM Medica Community.